.svg){kind=small}
May-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Market Insights Snapshot
In May 2026, 710 Labs leaned into a two-tier mix: Concentrates held 38.33% share with a year-over-year change of -2.75% and a month-over-month decline of -39.46%, while Flower accounted for 27.60% share with +11.96% YoY and -16.25% MoM. Vapor Pens represented 21.53% share with -4.72% YoY and -29.80% MoM, contrasted by Pre-Roll at 11.30% share with +60.05% YoY and a comparatively shallow -2.35% MoM; Edible remained small at 1.24% share but grew +16.64% YoY and +4.72% MoM. With the brand’s average price up 9.77% YoY to $32.17 and top state mix led by CA, the pattern signals reliance on premium-priced Concentrates and Vapor Pens even as short-term pullbacks shift incremental volume toward Pre-Roll and selected Edible SKUs.
The combined -39.46% MoM in Concentrates and -29.80% MoM in Vapor Pens, alongside a modest -2.35% MoM in Pre-Roll and a +4.72% MoM in Edible, implies a near-term elasticity pivot: consumers are trading into lower-ticket formats while retaining 710 Labs in their basket. Given Flower’s +11.96% YoY against a -16.25% MoM, and Pre-Roll’s +60.05% YoY at 11.30% share, the portfolio is diversifying around a Concentrates core without surrendering category leadership signals, evidenced by a Concentrates rank of 2 in Colorado; this positioning suggests a hedge where value-leaning formats buffer volatility in higher-priced segments while preserving halo from top-tier rankings.
Competitive Landscape
710 Labs ranks #3 in CA Concentrates in May 2026, improving 1 position from #4 year over year while holding steady versus February 2026 at #3; this sits below its peak of #1 in June 2024, marking a 2-place gap from peak to current. Against competitors, Raw Garden holds #1 with an 11.25% YoY sales increase while 710 Labs remains 2 spots behind, and STIIIZY is #2 with a -23.81% YoY sales change that places it 1 spot ahead despite contraction; meanwhile, Punch Extracts / Punch Edibles slid from #3 to #4 and CannaBiotix (CBX) stayed at #5 with an 8.20% YoY gain, framing 710 Labs’ upward 1-rank YoY move as relative outperformance versus one immediate follower but underperformance versus the category leader. The pattern implies 710 Labs’ return to #3 and distance from its June 2024 #1 peak define a stabilization phase where incremental share recovery is feasible if momentum persists against a weakening #2 and a growing #1.
Notable Products
The steepest movement in May 2026 was Terp Quest RSO Syringe (1g) dropping -10.27% month over month and holding rank 7, while Donny Burger Pre-Roll (1g) fell -20.48% to rank 8, signaling pressure on non-flower items versus the rest of the list. Lemon Tart Pucker #1 Pre-Roll (1g) was the lone climber with a +40.84% MoM surge at rank 4, yet it did not offset that concentrates pullback, and pre-rolls occupied four of the top ten ranks, indicating format concentration despite mixed momentum. With GG4 (Bulk) at rank 1 and Garlic Cocktail #7 (3.5g) at rank 10 generating $71,032 combined, flower bookends the ranking while pre-roll volatility compresses mid-table share, implying a tilt back toward core flower as the steadier commercial anchor.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
